Late treatment initiation leads to reduced antiviral potency
Xuanlin Liu, Evelyn J. Franco, Sean N. Avedissian…·Anne‐Grete Märtson
This study shows that late antiviral treatment initiation reduces drug potency (EC50), and a time-varying EC50 model better fits viral load data than a constant EC50 model.